BACKGROUND: In T-acute lymphoblastic leukemia (T-ALL), multi-parametric flow cytometry
can serve to detect minimal residual disease (MRD) by using immature or aberrant antigens …

Background. Minimal residual disease (MRD) is an independent prognostic factor in acute
lymphoblastic leukemia (ALL) in children. The immunological assessment of MRD cell count …

Immunophenotyping has become a primary modality in detection of minimal residual
disease (MRD) in acute leukemia. Detection and enumeration of leukemic blasts relies on …

Background T-lymphoblastic leukemia (T-ALL) patients expressing myeloid/stem cell
antigens are classified as early T-cell precursor lymphoblastic leukemia (ETP-ALL) or near …

Flow‐cytometric detection of minimal residual disease (MRD) identifies patients with high
relapse risk in childhood acute lymphoblastic leukaemia (ALL). We studied the efficacy of …

Abstract 4817 T-cell acute lymphoblastic leukemia (T-ALL) patients have increased risk for
treatment resistance and early relapse. The precise bone marrow evaluation for the …

Minimal residual disease (MRD) predicts the outcome of acute lymphoblastic leukemia
(ALL). Flow cytometry (FC) is one of the most sensitive and most applicable methods for …

Minimal residual disease (MRD) is an important independent prognostic factor for relapse
and survival in acute lymphoblastic leukaemia (ALL). Compared with adult B‐cell ALL …

A seven-color panel was used to detect minimal residual disease (MRD) in T cell acute
lymphoblastic leukemia (T-ALL) via flow cytometry (FCM). Its availability and clinical …

T‐lineage acute lymphoblastic leukemia (T‐ALL) accounts for about 15% of pediatric and
about 25% of adult ALL cases. Minimal/measurable residual disease (MRD) assessed by …